About Us
Open Innovation
in SAGA Global Research Center
Hisamitsu Pharmaceutical has developed various Transdermal Drug Delivery System (TDDS) technologies through focused research and development. Based on these technologies, we have created a range of products. To achieve our corporate mission of promoting “TE-A-TE” culture worldwide, we will enhance the development of innovative pharmaceutical products through open innovation and collaboration with external partners who bring different perspectives and ideas.
Opening of SAGA Global Research Center
We have newly established the SAGA Global Research Center, consolidating the research facilities previously located in Tosu City and Tsukuba City, as a research hub for TDDS formulation and technology development. This enables us to conduct a series of research activities, from drug discovery to product manufacturing, in close collaboration at a single research center. In addition, the SAGA Global Research Center offers collaborative experimental space (Open Laboratory) available for use by our partners. In joint research and other collaborative efforts, partners may utilize Hisamitsu Pharmaceutical’s state-of-the-art research equipment.
SAGA Global Research Center
Open Laboratory
Examples of experiments which can be conducted in the Open Laboratory:
・Lab-scale manufacturing of TDDS formulations
・Physicochemical analysis and experiments
・Skin permeation study
Wish List
To create partnering opportunities with academia and venture companies, Hisamitsu Pharmaceutical published a desired research topics Wish List.
If you have any inquiries regarding the Wish List or proposals for joint research, please apply using the form below.
